

| Catalog No. | HB638022 |
|---|---|
| Description |
Recombinant Human CBL Protein, N-His-KSI (HB638022) expressed in E. coli, spanning Asp52-Pro433. Purity: >90% by SDS-PAGE.
Highlights
|
| Expression system | E. coli |
| Accession | P22681 |
| Protein length | Asp52-Pro433 |
| Applications | ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Species | Homo sapiens (Human) |
| Nature | Recombinant |
| Endotoxin level | Please contact with the lab for this information. |
| Purity | >90% as determined by SDS-PAGE. |
| Predicted molecular weight | 59.92 kDa |
| Form | Lyophilized |
| Storage buffer | Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Reconstitution | Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details. |
| Shipping | In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | CBL, CBL2, Casitas B-lineage lymphoma proto-oncogene, E3 ubiquitin-protein ligase CBL, EC:2.3.2.27, Proto-oncogene c-Cbl, RING finger protein 55, RING-type E3 ubiquitin transferase CBL, RNF55, Signal transduction protein CBL |
| Background | E3 ubiquitin-protein ligase CBL is a ~99 kDa protein. E3 ubiquitin-protein ligase that acts as a negative regulator of many signaling pathways by mediating ubiquitination of cell surface receptors. Accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and then transfers it to substrates promoting their degradation by the proteasome. Recognizes activated receptor tyrosine kinases, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, CSF1R, EPHA8 and KDR and mediates their ubiquitination to terminate signaling. Recognizes membrane-bound HCK, SRC and other kinases of the SRC family and mediates their ubiquitination and degradation. Ubiquitinates EGFR and SPRY2. 1. Joazeiro, CA. et al. (1999) Science (New York, N.Y.) 286, 309-12. PMID: 10514377 2. Howlett, CJ. et al. (2002) Oncogene 21, 1707-16. PMID: 11896602 3. Kim, M. et al. (2004) Oncogene 23, 1645-55. PMID: 14661060 4. Miyazaki, T. et al. (2004) The Journal of biological chemistry 279, 17660-6. PMID: 14739300 5. Kaabeche, K. et al. (2004) The Journal of biological chemistry 279, 36259-67. PMID: 15190072 6. Bonaventure, J. et al. (2007) The FEBS journal 274, 3078-93. PMID: 17509076 7. Dufour, C. et al. (2008) Bone 42, 1032-9. PMID: 18374639 8. Wehrle, C. et al. (2009) The Biochemical journal 423, 375-80. PMID: 19689429 9. Sévère, N. et al. (2011) The Journal of biological chemistry 286, 24443-50. PMID: 21596750 10. Deschamps, T. et al. (2017) Journal of virology 91. PMID: 28381567 |
| Note | For research use only |
Contact us for custom quotes, bulk requests and any other issues.
Mail: [email protected]
+86-27-65523339
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский